News
ATR
115.26
+1.45%
1.65
AptarGroup Balances Profit Pressures With Pharma Momentum
TipRanks · 1d ago
Will Aptar's (ATR) New CAO and Award-Winning Clarins Partnership Reframe Its Innovation Narrative?
Simply Wall St · 1d ago
Weekly Report: what happened at ATR last week (0511-0515)?
Weekly Report · 2d ago
A Look At AptarGroup (ATR) Valuation After Recent Share Price Weakness
Simply Wall St · 4d ago
AptarGroup Appoints New Vice President and Chief Accounting Officer
TipRanks · 05/13 11:35
Weekly Report: what happened at ATR last week (0504-0508)?
Weekly Report · 05/11 09:04
AptarGroup Sets CEO Succession as 2025 Sales Rise and Shareholders Back Ballot
NASDAQ · 05/09 22:06
A Look At AptarGroup (ATR) Valuation After New Reloadable Airless And Lidless Packaging Launches
Simply Wall St · 05/09 05:52
Top AptarGroup Executive Makes Notable Insider Move That Investors Can’t Ignore
TipRanks · 05/09 02:07
AptarGroup Is Maintained at Overweight by Wells Fargo
Dow Jones · 05/04 19:03
Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $145
Benzinga · 05/04 18:53
Weekly Report: what happened at ATR last week (0427-0501)?
Weekly Report · 05/04 09:04
Analyst Estimates: Here's What Brokers Think Of AptarGroup, Inc. (NYSE:ATR) After Its First-Quarter Report
Simply Wall St · 05/03 13:10
AptarGroup Earnings Call Balances Growth With Margin Strain
TipRanks · 05/02 00:10
AptarGroup (ATR) Margin Compression Challenges Bullish Pharma Growth Narrative In Q1 2026
Simply Wall St · 05/01 22:46
Dividend Champion, Contender, And Challenger Highlights: Week Of May 3
Seeking Alpha · 05/01 22:04
Aptar forecasts Q2 adjusted EPS of $1.32-$1.40 as emergency medicine destocking tracks ~$65M 2026 headwind
Seeking Alpha · 05/01 20:32
AptarGroup (ATR) Q1 2026 Earnings Transcript
The Motley Fool · 05/01 14:40
Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR) and Viridian Therapeutics (VRDN)
TipRanks · 04/30 22:30
AptarGroup Inc. Reports Retreat In Q1 Income
NASDAQ · 04/30 21:42
More
Webull provides a variety of real-time ATR stock news. You can receive the latest news about Aptargroup through multiple platforms. This information may help you make smarter investment decisions.
About ATR
AptarGroup, Inc. is engaged in the design and manufacturing of drug and consumer product dosing, dispensing, and protection technologies. The Company serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care, and home care. It also manufactures and sells elastomeric primary packaging components. It operates through three segments, which include Pharma segment, Beauty segment, and Closures segment. The Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and health care markets worldwide. The Beauty segment sells pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care, and home care markets. The Closures segment includes dispensing and non-dispensing solutions that enable product delivery without removal of the cap and are used across multiple consumer end markets.